-+ 0.00%
-+ 0.00%
-+ 0.00%

IMMUNITYBIO ANNOUNCES ANKTIVA® IS NOW AVAILABLE IN SAUDI ARABIA FOR BLADDER AND LUNG CANCER PATIENTS; MARKET ENTRY ACHIEVED WITHIN TWO MONTHS OF MENA PARTNERSHIP

Reuters·04/21/2026 11:30:01

Please log in to view news